nodes	percent_of_prediction	percent_of_DWPC	metapath
Porfimer—LDLR—Diseases associated with visual transduction—SAG—ocular cancer	0.0908	0.0908	CbGpPWpGaD
Porfimer—LDLR—Wnt Signaling Pathway—CCND3—ocular cancer	0.0746	0.0746	CbGpPWpGaD
Porfimer—LDLR—DNA Damage Response (only ATM dependent)—RBL2—ocular cancer	0.0635	0.0635	CbGpPWpGaD
Porfimer—LDLR—Wnt Signaling Pathway and Pluripotency—CCND3—ocular cancer	0.0533	0.0533	CbGpPWpGaD
Porfimer—LDLR—DNA Damage Response (only ATM dependent)—CCND3—ocular cancer	0.0506	0.0506	CbGpPWpGaD
Porfimer—LDLR—Wnt Signaling Pathway—CCND2—ocular cancer	0.0478	0.0478	CbGpPWpGaD
Porfimer—LDLR—Oncostatin M Signaling Pathway—CDK2—ocular cancer	0.0348	0.0348	CbGpPWpGaD
Porfimer—LDLR—Wnt Signaling Pathway and Pluripotency—CCND2—ocular cancer	0.0342	0.0342	CbGpPWpGaD
Porfimer—LDLR—DNA Damage Response (only ATM dependent)—CCND2—ocular cancer	0.0324	0.0324	CbGpPWpGaD
Porfimer—LDLR—Oncostatin M Signaling Pathway—CDKN1B—ocular cancer	0.0222	0.0222	CbGpPWpGaD
Porfimer—LDLR—Wnt Signaling Pathway—CCND1—ocular cancer	0.0207	0.0207	CbGpPWpGaD
Porfimer—LDLR—Wnt Signaling Pathway—MYC—ocular cancer	0.0166	0.0166	CbGpPWpGaD
Porfimer—LDLR—DNA Damage Response (only ATM dependent)—MDM2—ocular cancer	0.0161	0.0161	CbGpPWpGaD
Porfimer—LDLR—Wnt Signaling Pathway and Pluripotency—CCND1—ocular cancer	0.0148	0.0148	CbGpPWpGaD
Porfimer—LDLR—DNA Damage Response (only ATM dependent)—CDKN1B—ocular cancer	0.0147	0.0147	CbGpPWpGaD
Porfimer—LDLR—Metabolism—PSPH—ocular cancer	0.0146	0.0146	CbGpPWpGaD
Porfimer—LDLR—DNA Damage Response (only ATM dependent)—CCND1—ocular cancer	0.014	0.014	CbGpPWpGaD
Porfimer—LDLR—Oncostatin M Signaling Pathway—TP53—ocular cancer	0.014	0.014	CbGpPWpGaD
Porfimer—LDLR—Folate Metabolism—TP53—ocular cancer	0.0138	0.0138	CbGpPWpGaD
Porfimer—LDLR—Wnt Signaling Pathway and Pluripotency—EP300—ocular cancer	0.0136	0.0136	CbGpPWpGaD
Porfimer—LDLR—DNA Damage Response (only ATM dependent)—CDKN1A—ocular cancer	0.0136	0.0136	CbGpPWpGaD
Porfimer—LDLR—Oncostatin M Signaling Pathway—HRAS—ocular cancer	0.0134	0.0134	CbGpPWpGaD
Porfimer—LDLR—Wnt Signaling Pathway and Pluripotency—MYC—ocular cancer	0.0119	0.0119	CbGpPWpGaD
Porfimer—LDLR—Oncostatin M Signaling Pathway—AKT1—ocular cancer	0.0118	0.0118	CbGpPWpGaD
Porfimer—LDLR—Disease—SAG—ocular cancer	0.0115	0.0115	CbGpPWpGaD
Porfimer—LDLR—DNA Damage Response (only ATM dependent)—MYC—ocular cancer	0.0113	0.0113	CbGpPWpGaD
Porfimer—LDLR—SREBP signalling—AKT1—ocular cancer	0.0113	0.0113	CbGpPWpGaD
Porfimer—LDLR—DNA Damage Response (only ATM dependent)—TGFB1—ocular cancer	0.0112	0.0112	CbGpPWpGaD
Porfimer—LDLR—Disease—E2F5—ocular cancer	0.0102	0.0102	CbGpPWpGaD
Porfimer—LDLR—Disease—E2F4—ocular cancer	0.01	0.01	CbGpPWpGaD
Porfimer—LDLR—Disease—RPL39—ocular cancer	0.00981	0.00981	CbGpPWpGaD
Porfimer—LDLR—Disease—RBL1—ocular cancer	0.00981	0.00981	CbGpPWpGaD
Porfimer—LDLR—Wnt Signaling Pathway and Pluripotency—TP53—ocular cancer	0.00975	0.00975	CbGpPWpGaD
Porfimer—LDLR—DNA Damage Response (only ATM dependent)—TP53—ocular cancer	0.00924	0.00924	CbGpPWpGaD
Porfimer—LDLR—DNA Damage Response (only ATM dependent)—HRAS—ocular cancer	0.00884	0.00884	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—SAG—ocular cancer	0.00808	0.00808	CbGpPWpGaD
Porfimer—LDLR—Disease—TFDP1—ocular cancer	0.00791	0.00791	CbGpPWpGaD
Porfimer—LDLR—DNA Damage Response (only ATM dependent)—AKT1—ocular cancer	0.0078	0.0078	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—E2F5—ocular cancer	0.00715	0.00715	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—E2F4—ocular cancer	0.007	0.007	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—RBL1—ocular cancer	0.00687	0.00687	CbGpPWpGaD
Porfimer—LDLR—Disease—MAML2—ocular cancer	0.00628	0.00628	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—E2F3—ocular cancer	0.00596	0.00596	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—TFDP1—ocular cancer	0.00554	0.00554	CbGpPWpGaD
Porfimer—LDLR—Disease—HDAC1—ocular cancer	0.00459	0.00459	CbGpPWpGaD
Porfimer—LDLR—Metabolism—GNA11—ocular cancer	0.00459	0.00459	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—MAML2—ocular cancer	0.0044	0.0044	CbGpPWpGaD
Porfimer—LDLR—Metabolism—GNAQ—ocular cancer	0.00427	0.00427	CbGpPWpGaD
Porfimer—LDLR—Disease—CDKN2B—ocular cancer	0.00412	0.00412	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—MDM2—ocular cancer	0.00397	0.00397	CbGpPWpGaD
Porfimer—FCGR1A—Cytokine Signaling in Immune system—HRAS—ocular cancer	0.00389	0.00389	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—GNA11—ocular cancer	0.00384	0.00384	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—MDM2—ocular cancer	0.00381	0.00381	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—CDKN1B—ocular cancer	0.00363	0.00363	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—GNAQ—ocular cancer	0.00357	0.00357	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—CDKN1B—ocular cancer	0.00348	0.00348	CbGpPWpGaD
Porfimer—LDLR—Metabolism of lipids and lipoproteins—EP300—ocular cancer	0.00344	0.00344	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—CDKN1A—ocular cancer	0.00335	0.00335	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—HDAC1—ocular cancer	0.00322	0.00322	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—CDKN1A—ocular cancer	0.00321	0.00321	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—EP300—ocular cancer	0.00318	0.00318	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CDKN2B—ocular cancer	0.00288	0.00288	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—E2F1—ocular cancer	0.00265	0.00265	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—MDM2—ocular cancer	0.00231	0.00231	CbGpPWpGaD
Porfimer—LDLR—Disease—MDM2—ocular cancer	0.00228	0.00228	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—HRAS—ocular cancer	0.00218	0.00218	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CDKN1B—ocular cancer	0.00211	0.00211	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—HRAS—ocular cancer	0.00209	0.00209	CbGpPWpGaD
Porfimer—LDLR—Disease—CDKN1B—ocular cancer	0.00209	0.00209	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—CDKN1A—ocular cancer	0.00195	0.00195	CbGpPWpGaD
Porfimer—FCGR1A—Innate Immune System—AKT1—ocular cancer	0.00192	0.00192	CbGpPWpGaD
Porfimer—LDLR—Disease—CDKN1A—ocular cancer	0.00192	0.00192	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—EP300—ocular cancer	0.00185	0.00185	CbGpPWpGaD
Porfimer—FCGR1A—Adaptive Immune System—AKT1—ocular cancer	0.00185	0.00185	CbGpPWpGaD
Porfimer—LDLR—Disease—EP300—ocular cancer	0.00183	0.00183	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—MDM2—ocular cancer	0.0016	0.0016	CbGpPWpGaD
Porfimer—LDLR—Disease—MYC—ocular cancer	0.0016	0.0016	CbGpPWpGaD
Porfimer—LDLR—Disease—TGFB1—ocular cancer	0.00159	0.00159	CbGpPWpGaD
Porfimer—LDLR—Metabolism—EP300—ocular cancer	0.00153	0.00153	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CDKN1B—ocular cancer	0.00146	0.00146	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CCND1—ocular cancer	0.00139	0.00139	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—CDKN1A—ocular cancer	0.00135	0.00135	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—EP300—ocular cancer	0.00128	0.00128	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—HRAS—ocular cancer	0.00127	0.00127	CbGpPWpGaD
Porfimer—LDLR—Disease—HRAS—ocular cancer	0.00125	0.00125	CbGpPWpGaD
Porfimer—FCGR1A—Immune System—AKT1—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—MYC—ocular cancer	0.00112	0.00112	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—TGFB1—ocular cancer	0.00111	0.00111	CbGpPWpGaD
Porfimer—LDLR—Disease—AKT1—ocular cancer	0.00111	0.00111	CbGpPWpGaD
Porfimer—LDLR—Metabolism—AKT1—ocular cancer	0.000927	0.000927	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—TP53—ocular cancer	0.000918	0.000918	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—HRAS—ocular cancer	0.000878	0.000878	CbGpPWpGaD
Porfimer—LDLR—Signaling Pathways—AKT1—ocular cancer	0.000775	0.000775	CbGpPWpGaD
